Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
J Cancer ; 14(15): 2798-2810, 2023.
Article in English | MEDLINE | ID: mdl-37781084

ABSTRACT

Tripartite motif-containing protein 28 (TRIM28), as a transcriptional cofactor, has pleiotropic biological effects, such as silencing genes, promoting cellular proliferation and differentiation, and facilitating DNA repair. It is reported that TRIM28 is also correlated with immune infiltration in liver cancer that highlights an unnoticed function of TRIM28 in immune system. However, the prognostic and immunotherapeutic role of TRIM28 in human cancer has not been elucidated. In this study, we conducted a systematic pan-cancer analysis and partial experimental validation of TRIM28 as an immunological and prognostic predictor and its involvement in immunotherapy resistance. We found that TRIM28 expression was higher in various tumor tissues than in normal tissues. Higher TRIM28 expression was associated with poorer prognosis in multiple cancers. The expression of TRIM28 was positively correlated with the presence of T cells, macrophages and neutrophils, and TRIM28 also promoted the infiltration of a series of immune cell. Moreover, TRIM28 affected a wide range of cancer-related scores, and the abnormal expression of TRIM28 was also involved in tumor mutational burden, drug sensitivity, and microsatellite instability in cancer. The results suggest that TRIM28 is a potentially valuable immune response indicator and a molecular biomarker for predicting the prognosis of cancer patients.

2.
Cell Rep Med ; 4(9): 101166, 2023 09 19.
Article in English | MEDLINE | ID: mdl-37633276

ABSTRACT

Upper tract urothelial carcinoma (UTUC) is often diagnosed late and exhibits poor prognosis. Limited data are available on potential non-invasive biomarkers for disease monitoring. Here, we investigate the proteomic profile of plasma in 362 UTUC patients and 239 healthy controls. We present an integrated tissue-plasma proteomic approach to infer the signature proteins for identifying patients with muscle-invasive UTUC. We discover a protein panel that reflects lymph node metastasis, which is of interest in identifying UTUC patients with high risk and poor prognosis. We also identify a ten-protein classifier and establish a progression clock predicting progression-free survival of UTUC patients. Finally, we further validate the signature proteins by parallel reaction monitoring assay in an independent cohort. Collectively, this study portrays the plasma proteomic landscape of a UTUC cohort and provides a valuable resource for further biological and diagnostic research in UTUC.


Subject(s)
Carcinoma, Transitional Cell , Urinary Bladder Neoplasms , Humans , Carcinoma, Transitional Cell/diagnosis , Proteomics , Lymphatic Metastasis , Muscles
3.
Acc Chem Res ; 56(14): 2001-2014, 2023 Jul 18.
Article in English | MEDLINE | ID: mdl-37402692

ABSTRACT

ConspectusThe methanol-to-hydrocarbons (MTH) process has provided a new route to obtaining basic chemicals without relying on an oil resource. Acidity and shape selectivity endow the zeolite with a decisive role in MTH catalysis. However, the inherent reaction characteristics of the MTH reaction over zeolites, such as the complexity of catalytic reaction kinetics, the diversity of catalytic reaction modes, and even the limitations of catalytic and diffusive decoupling, have all confused people with respect to obtaining a comprehensive mechanistic understanding. By examining the zeolite-catalyzed MTH reaction from the perspective of chemical bonding, one would realize that this reaction reflects the dynamic assembly process of C-C bonds from C1 components to multicarbon products. The key to understanding the MTH reaction lies in the mechanism by which C-C bonds are formed and rearranged in the confined microenvironment of the channel or cage structures of zeolite catalysts to achieve shape-selective production.The applications of advanced in situ spectroscopy as well as computational chemistry provide tremendous opportunities for capturing and identifying the details of the structure and properties of reactants, intermediates, and products in the confined reaction space of zeolite channels or cages, observing the real-time dynamic evolution of the catalytic surface, and modeling the elementary reaction steps at the molecular and atomic levels.In this Account, the dynamic catalytic mechanism of the zeolite-catalyzed MTH reaction will be outlined based on decades of continuous research and in-depth understanding. The combination of advanced in situ spectroscopy and theoretical methods allowed us to observe and simulate the formation, growth, and aging process on the working catalyst surface and thus map the dynamical evolution of active sites from a Brønsted acid site (BAS) to an organic-inorganic hybrid supramolecule (OIHS) in the MTH reaction. Moreover, the ever-evolving dynamic succession of the OIHS from surface methoxy species (SMS) to active ion-pair complexes (AIPC) to inert complexes (IC) guided the dynamic autocatalytic process from initiation to sustaining and then to termination, resulting in a complex interlaced hypercycle reaction network. The concept of dynamic catalysis will provide deep insight into the complex catalytic mechanisms as well as the structure-activity relationships in MTH chemistry. More importantly, we are now getting closer to the nature of zeolite catalysis beyond the traditional view of BAS catalysis.

4.
Nat Commun ; 14(1): 4274, 2023 07 17.
Article in English | MEDLINE | ID: mdl-37460463

ABSTRACT

The tyrosine kinase inhibitor (TKI) Sunitinib is one the therapies approved for advanced renal cell carcinoma. Here, we undertake proteogenomic profiling of 115 tumors from patients with clear cell renal cell carcinoma (ccRCC) undergoing Sunitinib treatment and reveal the molecular basis of differential clinical outcomes with TKI therapy. We find that chromosome 7q gain-induced mTOR signaling activation is associated with poor therapeutic outcomes with Sunitinib treatment, whereas the aristolochic acid signature and VHL mutation synergistically caused enhanced glycolysis is correlated with better prognosis. The proteomic and phosphoproteomic analysis further highlights the responsibility of mTOR signaling for non-response to Sunitinib. Immune landscape characterization reveals diverse tumor microenvironment subsets in ccRCC. Finally, we construct a multi-omics classifier that can detect responder and non-responder patients (receiver operating characteristic-area under the curve, 0.98). Our study highlights associations between ccRCC molecular characteristics and the response to TKI, which can facilitate future improvement of therapeutic responses.


Subject(s)
Carcinoma, Renal Cell , Kidney Neoplasms , Proteogenomics , Humans , Carcinoma, Renal Cell/drug therapy , Carcinoma, Renal Cell/genetics , Carcinoma, Renal Cell/pathology , Sunitinib/therapeutic use , Kidney Neoplasms/drug therapy , Kidney Neoplasms/genetics , Kidney Neoplasms/pathology , Proteomics , Protein Kinase Inhibitors/pharmacology , Protein Kinase Inhibitors/therapeutic use , TOR Serine-Threonine Kinases/genetics , Tumor Microenvironment
5.
Nanomaterials (Basel) ; 13(2)2023 Jan 12.
Article in English | MEDLINE | ID: mdl-36678073

ABSTRACT

By means of a pipe's inner surface grinding, a single-phase nanostructured austenite was formed on the surface of an AISI 304 stainless steel. The electrochemical corrosion behavior was compared with a coarse-grained counterpart of identical surface roughness. Experimental results show that the nanostructured austenite shows a higher pitting potential and a wider passivation interval than those of its coarse-grained counterpart. The enhanced corrosion resistance was attributed to the fast diffusion of Cr within the nanostructure and, hence, the formation of a thicker passive film to efficiently protect the surface against the ion attack. This work provides insights into a simple processing method to improve the surface strength and pitting resistance of stainless steel.

6.
Materials (Basel) ; 15(15)2022 Aug 07.
Article in English | MEDLINE | ID: mdl-35955369

ABSTRACT

Crevice corrosion behavior of Alloy 690 in high-temperature aerated chloride solution was studied using a self-designed crevice device. The SEM, EDS, XRD, and XPS analyses results indicated that the oxide films outside the crevice consisted of Ni-Cr oxides containing a small amount of hydroxides, and the oxide films on crevice mouth consisted of a (Ni,Fe)(Fe,Cr)2O4 spinel oxides outer layer and a Cr(OH)3 inner layer, and the oxide films inside the crevice consisted of a α-CrOOH outer layer and a Cr(OH)3 inner layer. When crevice corrosion occurred, the hydrolysis of Cr3+ led to the formation of Cr(OH)3 inside the crevice, and caused the pH value of crevice solution to decrease, and Cl- migrated from outside the crevice into inside the crevice due to electrical neutrality principle and accumulation. When the water chemistry inside the crevice reached the critical value of active dissolution of metal, the active dissolution of metal inside the crevice occurred. In addition, (Ni,Fe)(Fe,Cr)2O4 spinel oxides on the crevice mouth were formed by the deposition of metal ions migrated from inside the crevice. The mechanism of crevice corrosion and the formation mechanism of oxide films at different regions were also discussed.

7.
Bioengineered ; 13(5): 14000-14012, 2022 05.
Article in English | MEDLINE | ID: mdl-35726370

ABSTRACT

Tribbles homolog 3 (TRIB3), a pseudokinase that regulates multiple intracellular signaling pathways, has been reported to promote the growth of multiple tumors. However, its role in clear cell renal cell carcinoma (ccRCC) remains unelucidated. We evaluated the role of TRIB3 in ccRCC using publicly available data from The Cancer Genome Atlas and analyzed its relationship with the tumor microenvironment; moreover, we used gene knockout and overexpression techniques to detect the effects of TRIB3 on the biological behavior of ccRCC cells. RT-qPCR and western blotting were used to detect transfection efficiency, and the invasiveness of ccRCC cells was determined by Transwell migration assays. We found that TRIB3 overexpression was significantly associated with increased grade, stage, and distant metastasis, positively correlated with ccRCC invasiveness, and also an independent risk factor for overall survival (OS). In addition, 361 differentially expressed genes (DEGs) related to TRIB3 were identified. Functional enrichment analysis showed that DEGs were mainly enriched in humoral immune responses, collagen-containing extracellular matrix, and serine hydrolase activity. Immune landscape characterization revealed that TRIB3 expression was significantly and negatively associated with CD8+ T and hematopoietic stem cells, whereas it was positively associated with NK T and macrophage M1 cells. Single-cell sequencing showed that localization and binding targets of TRIB3 mainly involved monocytes/macrophages and CD4+ and CD8+ T cells. Overall, our study revealed that elevated TRIB3 expression represents a promising prognostic marker for ccRCC patients and may play a key role in tumor microenvironment modulation.


Subject(s)
Carcinoma, Renal Cell , Cell Cycle Proteins/metabolism , Kidney Neoplasms , Protein Serine-Threonine Kinases/antagonists & inhibitors , Repressor Proteins/metabolism , Biomarkers, Tumor/genetics , CD8-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/pathology , Carcinoma, Renal Cell/metabolism , Computational Biology , Gene Expression Regulation, Neoplastic , Humans , Kidney Neoplasms/genetics , Kidney Neoplasms/pathology , Prognosis , Protein Serine-Threonine Kinases/metabolism , Tumor Microenvironment/genetics
8.
Cell Mol Life Sci ; 78(24): 8261-8281, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34773477

ABSTRACT

Colorectal cancer (CRC) is the leading cause of cancer-related mortality worldwide, which makes it urgent to identify novel therapeutic targets for CRC treatment. In this study, DHX9 was filtered out as the prominent proliferation promoters of CRC by siRNA screening. Moreover, DHX9 was overexpressed in CRC cell lines, clinical CRC tissues and colitis-associated colorectal cancer (CAC) mouse model. The upregulation of DHX9 was positively correlated with poor prognosis in patients with CRC. Through gain- and loss-of function experiments, we found that DHX9 promoted CRC cell proliferation, colony formation, apoptosis resistance, migration and invasion in vitro. Furthermore, a xenograft mouse model and a hepatic metastasis mouse model were utilized to confirm that forced overexpression of DHX9 enhanced CRC outgrowth and metastasis in vivo, while DHX9 ablation produced the opposite effect. Mechanistically, from one aspect, DHX9 enhances p65 phosphorylation, promotes p65 nuclear translocation to facilitate NF-κB-mediated transcriptional activity. From another aspect, DHX9 interacts with p65 and RNA polymerase II (RNA Pol II) to enhance the downstream targets of NF-κB (e.g., Survivin, Snail) expression to potentiate the malignant phenotypes of CRC. Together, our results suggest that DHX9 may be a potential therapeutic target for prevention and treatment of CRC patients.


Subject(s)
Biomarkers, Tumor/metabolism , Colorectal Neoplasms/pathology , DEAD-box RNA Helicases/metabolism , Epithelial-Mesenchymal Transition , Gene Expression Regulation, Neoplastic , Liver Neoplasms/secondary , NF-kappa B/metabolism , Neoplasm Proteins/metabolism , Animals , Apoptosis , Biomarkers, Tumor/genetics , Cell Proliferation , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , DEAD-box RNA Helicases/antagonists & inhibitors , DEAD-box RNA Helicases/genetics , Humans , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Nude , NF-kappa B/genetics , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Prognosis , RNA, Small Interfering/genetics , Signal Transduction , Survival Rate , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
9.
Photodiagnosis Photodyn Ther ; 35: 102429, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34237475

ABSTRACT

Black phosphorus quantum dots(BPQDs) have shown a good application prospect in the field of tumor therapy due to their photoelectric effect and good biodegradability. Due to the active endocytosis and fast metabolic efficiency of tumor cells, BPQDs are easy to be absorbed by tumor cells. However, this does not guarantee that BPQDs will be completely targeted to tumor cells, and normal cells will also absorb BPQDs. Because the cell membrane is negatively charged, BPQDs are also negatively charged and are not easily absorbed by cells under the action of electrostatic repulsion. Surface pegylation is the most common modification method of black phosphorus at present. However, surface pegylation can reduce the uptake of BPQDs by tumor cells. Positive PEG is also easy to be recognized and swallowed by the reticuloendothelial system. The inherent instability and poor tumor targeting of BPQDs under physiological conditions limit further research and clinical application. For this purpose, we selected cationic polymer polyethylenimine (PEI) to modify BPQDs and then added RGD peptides targeting tumor cells. An outer layer of negatively charged PEG+DMMA makes the nanosystem more stable . In the acidic environment of the tumor, the PEG layer has a charge reversal, and the positively charged PEI and the RGD polypeptide BPQDs targeted by the tumor cells are released into the tumor cells. It provides a new method for efficiently and accurately transporting BPQDs, a novel photosensitive nanomaterial, into tumor cells for photodynamic therapy.


Subject(s)
Photochemotherapy , Quantum Dots , Hydrogen-Ion Concentration , Phosphorus , Photochemotherapy/methods , Photosensitizing Agents
10.
J Am Chem Soc ; 143(31): 12038-12052, 2021 08 11.
Article in English | MEDLINE | ID: mdl-34319735

ABSTRACT

The industrially important methanol-to-hydrocarbons (MTH) reaction is driven and sustained by autocatalysis in a dynamic and complex manner. Hitherto, the entire molecular routes and chemical nature of the autocatalytic network have not been well understood. Herein, with a multitechnique approach and multiscale analysis, we have obtained a full theoretical picture of the domino cascade of autocatalytic reaction network taking place on HZSM-5 zeolite. The autocatalytic reaction is demonstrated to be plausibly initiated by reacting dimethyl ether (DME) with the surface methoxy species (SMS) to generate the initial olefins, as evidenced by combining the kinetic analysis, in situ DRIFT spectroscopy, 2D 13C-13C MAS NMR, electronic states, and projected density of state (PDOS) analysis. This process is operando tracked and visualized at the picosecond time scale by advanced ab initio molecular dynamics (AIMD) simulations. The initial olefins ignite autocatalysis by building the first autocatalytic cycle-olefins-based cycle-followed by the speciation of methylcyclopentenyl (MCP) and aromatic cyclic active species. In doing so, the active sites accomplish the dynamic evolution from proton acid sites to supramolecular active centers that are experimentally identified with an ever-evolving and fluid feature. The olefins-guided and cyclic-species-guided catalytic cycles are interdependently linked to forge a previously unidentified hypercycle, being composed of one "selfish" autocatalytic cycle (i.e., olefins-based cycle with lighter olefins as autocatalysts for catalyzing the formation of olefins) and three cross-catalysis cycles (with olefinic, MCP, and aromatic species as autocatalysts for catalyzing each other's formation). The unraveled dynamic autocatalytic cycles/network would facilitate the catalyst design and process control for MTH technology.

11.
ACS Cent Sci ; 7(4): 681-687, 2021 Apr 28.
Article in English | MEDLINE | ID: mdl-34056098

ABSTRACT

Direct observation of the activation and transformation of reactant molecules is extremely attractive but very challenging in the study of most chemical processes. Here is reported the first case of dynamic activation of C1 molecules in zeolite-catalyzed chemistry. During the methanol conversion over the HZSM-5 zeolite, a sequence of progressive activation states of dimethyl ether (DME) evoked by the special catalysis from CH3-Zeo, a hybrid supramolecular catalytic system formed by the organic methylic species growing on the inorganic silico-aluminate zeolite framework, has been directly observed by in situ ssNMR spectroscopy at programmed temperatures. Operando simulations visually display the variability of this hybrid supramolecular system of which the C-O bond property goes through a dynamic transition from covalent to ionic with the temperature increase, and thus the gradually enhanced electrophilicity of CH3 δ+ and nucleophilicity of Zeo δ- lead to the dynamic activation of DME. This dynamic transition is generally reflected in the alkyl-Zeo system with other alkoxy groups, which linked the alkoxy species and carbocations in zeolite catalysis. Consequently, this work not only sheds light on the key issue of the first carbon-carbon (C-C) bond formation in the methanol to hydrocarbons (MTH) process but also brings a new awareness on the essence of acid catalysis in zeolite mediated chemical processes.

12.
J Nanobiotechnology ; 19(1): 160, 2021 May 29.
Article in English | MEDLINE | ID: mdl-34051801

ABSTRACT

Photodynamic therapy (PDT) is a non-invasive or minimally-invasive treatment which applies photosensitizers (PSs) to create reactive oxygen species (ROS) exposed to light trigger to destroy cancer cells. PDT can activate host anti-tumor immune responses but not powerful enough to kill metastatic tumors. Because of its carrier advantage, imaging, and therapeutic function together with enhanced permeability and retention (EPR) effect, nano-materials have already been used in photo-immunotherapy. Herein, photodynamic immunotherapy (PDIT) based on nanotechnology seems to be a hopeful new form of cancer therapy. In this article, we firstly summarize the recent development in photodynamic immunotherapy based on nanotechnology.


Subject(s)
Immunotherapy/methods , Nanotechnology , Neoplasms/drug therapy , Photochemotherapy/methods , Animals , Cell Line, Tumor , Humans , Nanoparticles/therapeutic use , Neoplasms/pathology , Photosensitizing Agents/therapeutic use , Reactive Oxygen Species
13.
Chem Commun (Camb) ; 56(58): 8063-8066, 2020 Jul 21.
Article in English | MEDLINE | ID: mdl-32542269

ABSTRACT

The evolution of retained species during the whole methanol-to-olefins process was revealed with the aid of GC-MS, thermogravimetric analysis (TG) and density functional theory (DFT) calculations. Precise routes for the transformation of retained methylbenzenes to methylnaphthalenes were proposed, based on the direct capture of three possible organic intermediates, to explain the catalyst deactivation procedure.

14.
Surg Endosc ; 33(1): 206-215, 2019 01.
Article in English | MEDLINE | ID: mdl-29987565

ABSTRACT

BACKGROUND: Although laparoscopic liver resection (LLR) has advanced into a safe and effective alternative to conventional open liver resection (OLR), it has not been widely accepted by surgeons. This article aimed to investigate the perioperative and long-term benefits of LLR versus OLR for hepatocellular carcinoma (HCC) in selected patients with well-preserved liver function and cirrhotic background. METHODS: A retrospective study was conducted on 1085 patients with HCC who underwent liver resection at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University from July 2010 to July 2015, and 346 patients with well-preserved liver function and cirrhotic background were selected. A 1:1 propensity score matching (PSM), which is the best option to overcome selection bias, was conducted to compare the surgical outcomes and long-term prognosis between LLR and OLR. After PSM, a logistic regression analysis was used to identify the predictive risk factors of posthepatectomy liver failure (PHLF). RESULTS: By using PSM, the two groups were well balanced with 86 patients in each group. In the LLR group, only the median operation time was significantly longer than the OLR group, but the hospital stay, overall morbidity, and the incidence of PHLF were significantly decreased compared to OLR. There were no significant differences in the overall survival and disease-free survival rates between the two groups. On multivariate analysis, OLR was identified to be the only independent risk factor for PHLF. CONCLUSIONS: In selected HCC patients with well-preserved liver function and cirrhotic background, LLR could be a better option compared to OLR.


Subject(s)
Carcinoma, Hepatocellular/surgery , Hepatectomy/methods , Laparoscopy/methods , Liver Cirrhosis/surgery , Liver Neoplasms/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/diagnosis , Disease-Free Survival , Female , Follow-Up Studies , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/diagnosis , Liver Neoplasms/complications , Liver Neoplasms/diagnosis , Male , Middle Aged , Neoplasm Staging , Perioperative Period , Prognosis , Propensity Score , Retrospective Studies , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
15.
J Cancer ; 9(14): 2510-2517, 2018.
Article in English | MEDLINE | ID: mdl-30026849

ABSTRACT

Colorectal cancer (CRC) is one of the major health threats in developed countries. Changes in dietary components, such as more protein and lipid intake, can increase the risk of CRC. Diet affects CRC in many ways. They regulate the composition and function of gut microbiota, which have an amazing metabolic capacity and can produce short chain fatty acids (SCFAs), such as propionate, acetate, and butyrate. Butyrate is a principal energy source for colonic epithelial cells and plays an important role in maintaining the stability of gut microbiota and the integrity of intestinal epithelium. However, there are few studies reviewing the anti-CRC potentials of butyrate. This review summarizes the recent research progresses in the effect of gut microbiota imbalance and the decrease in intestinal microbial metabolite butyrate caused by unbalanced diet on CRC development, and discusses the mechanisms of butyrate-induced anti-CRC activities, which may guide people to prevent CRC by improving diet structures.

16.
Transl Res ; 190: 51-60, 2017 12.
Article in English | MEDLINE | ID: mdl-28917654

ABSTRACT

Cancer is a major cause of death worldwide, and its incidence and mortality continuously increase in China. Nowadays, cancer heavily influences our health and constitutes enormous burden on society and families. Although there are many tools for cancer treatment, but the overall therapeutic effect is poor. In addition, cancer cells often develop resistance to therapy due to defective cell death or immune escape mechanisms. Therefore, it is a promising way for cancer treatment to effectively activate apoptosis and conquer immunosuppression. RIG-I-like receptors (RLRs) belong to RNA-sensing pattern recognition receptors (PRRs), one of the major subsets of PRRs, and play a critical role in sensing RNA viruses and initiate host antiviral responses such as the production of type I interferons (IFNs), proinflammatory cytokines, and other immune response molecules. Recent studies have demonstrated that tumor cells could mimic viral infection to activate viral recognition of immune system and the activation of interferon response pathway. RIG-I and MDA5, two members of RLRs family, could induce growth inhibition or apoptosis of multiple types of cancer cells on the activation by RNA ligands in IFN-dependent or IFN-independent approach. Previous studies have reviewed PRRs as promising immunotherapy targets for colorectal cancer and pancreatic cancer. However, until now, a comprehensive review on the role of RLRs in the development and treatment of various cancers is still lacking. In this article, we reviewed the latest studies on the roles as well as the mechanisms of RIG-I and MDA5 in the development of various cancers and therapeutic potentials of targeting RIG-I and MDA5 for cancer treatment.


Subject(s)
DEAD Box Protein 58/metabolism , Interferon-Induced Helicase, IFIH1/metabolism , Neoplasms/drug therapy , Neoplasms/metabolism , Antineoplastic Agents/therapeutic use , DEAD Box Protein 58/genetics , Gene Expression Regulation, Neoplastic/immunology , Humans , Interferon-Induced Helicase, IFIH1/genetics , Receptors, Immunologic
17.
Angew Chem Int Ed Engl ; 56(31): 9039-9043, 2017 07 24.
Article in English | MEDLINE | ID: mdl-28503894

ABSTRACT

In the past two decades, the reaction mechanism of C-C bond formation from either methanol or dimethyl ether (DME) in the methanol-to-hydrocarbons (MTH) process has been a highly controversial issue. Described here is the first observation of a surface methyleneoxy analogue, originating from the surface-activated DME, by in situ solid-state NMR spectroscopy, a species crucial to the first C-C bond formation in the MTH process. New insights into the first C-C bond formation were provided, thus suggesting DME/methanol activation and direct C-C bond formation by an interesting synergetic mechanism, involving C-H bond breakage and C-C bond coupling during the initial methanol reaction within the chemical environment of the zeolite catalyst.

SELECTION OF CITATIONS
SEARCH DETAIL